CG Oncology IncNASDAQ:CGON
- LAST PRICE31.4300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots30.0900/ 5
- Ask / Lots32.0000/ 5
- Open / Previous Close0.0000 / 31.4300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGON |
|---|---|---|
| 09:32 ET | 34667 | 31.99 |
| 09:34 ET | 2400 | 31.995 |
| 09:36 ET | 900 | 31.83 |
| 09:38 ET | 1283 | 32.37 |
| 09:39 ET | 2400 | 32.46 |
| 09:41 ET | 100 | 32.57 |
| 09:48 ET | 1402 | 32.57 |
| 09:50 ET | 800 | 32.63 |
| 09:52 ET | 100 | 32.65 |
| 09:57 ET | 700 | 32.65 |
| 09:59 ET | 200 | 32.89 |
| 10:01 ET | 300 | 32.94 |
| 10:03 ET | 5490 | 32.405 |
| 10:06 ET | 1050 | 32.27 |
| 10:08 ET | 1600 | 32.08 |
| 10:10 ET | 1672 | 31.81 |
| 10:14 ET | 1200 | 31.595 |
| 10:15 ET | 2088 | 31.63 |
| 10:17 ET | 2174 | 31.36 |
| 10:19 ET | 454 | 31.23 |
| 10:21 ET | 940 | 31.275 |
| 10:24 ET | 722 | 31.42 |
| 10:28 ET | 500 | 31.55 |
| 10:30 ET | 100 | 31.545 |
| 10:32 ET | 2636 | 31.68 |
| 10:33 ET | 4227 | 31.875 |
| 10:35 ET | 4100 | 31.955 |
| 10:37 ET | 3253 | 32.06 |
| 10:39 ET | 3787 | 32.08 |
| 10:42 ET | 2250 | 32.08 |
| 10:44 ET | 3348 | 32.09 |
| 10:46 ET | 3419 | 32.09 |
| 10:48 ET | 3326 | 31.935 |
| 10:50 ET | 6186 | 31.68 |
| 10:51 ET | 2000 | 31.64 |
| 10:53 ET | 5900 | 31.775 |
| 10:55 ET | 2999 | 31.87 |
| 10:57 ET | 2568 | 31.98 |
| 11:00 ET | 3850 | 32.03 |
| 11:02 ET | 2350 | 32.12 |
| 11:04 ET | 1400 | 32.21 |
| 11:06 ET | 2620 | 32.2125 |
| 11:08 ET | 2000 | 32.25 |
| 11:09 ET | 1464 | 32.25 |
| 11:11 ET | 2936 | 32.23 |
| 11:13 ET | 2658 | 32.165 |
| 11:15 ET | 6190 | 31.72 |
| 11:18 ET | 2900 | 31.465 |
| 11:20 ET | 2656 | 31.48 |
| 11:22 ET | 8344 | 31.72 |
| 11:24 ET | 5786 | 31.97 |
| 11:26 ET | 1700 | 32.09 |
| 11:27 ET | 2566 | 32.04 |
| 11:29 ET | 4727 | 31.88 |
| 11:31 ET | 3169 | 31.82 |
| 11:33 ET | 1000 | 31.75 |
| 11:36 ET | 5552 | 31.85 |
| 11:38 ET | 5015 | 31.8 |
| 11:40 ET | 1650 | 31.84 |
| 11:42 ET | 4290 | 31.97 |
| 11:44 ET | 1750 | 32.06 |
| 11:45 ET | 1900 | 32.06 |
| 11:47 ET | 3791 | 32.005 |
| 11:49 ET | 1959 | 31.98 |
| 11:51 ET | 1500 | 31.98 |
| 11:54 ET | 4451 | 31.63 |
| 11:56 ET | 2100 | 31.54 |
| 11:58 ET | 4350 | 31.3765 |
| 12:00 ET | 15583 | 31.5 |
| 12:02 ET | 4050 | 31.7 |
| 12:03 ET | 1386 | 31.755 |
| 12:05 ET | 3990 | 31.6719 |
| 12:07 ET | 1500 | 31.71 |
| 12:09 ET | 4622 | 31.51 |
| 12:12 ET | 2755 | 31.54 |
| 12:14 ET | 4882 | 31.66 |
| 12:16 ET | 3721 | 31.66 |
| 12:18 ET | 3196 | 31.61 |
| 12:20 ET | 2091 | 31.61 |
| 12:21 ET | 2762 | 31.71 |
| 12:23 ET | 3129 | 31.77 |
| 12:25 ET | 2044 | 31.83 |
| 12:27 ET | 5000 | 31.52 |
| 12:30 ET | 1200 | 31.585 |
| 12:32 ET | 2800 | 31.58 |
| 12:34 ET | 2500 | 31.54 |
| 12:36 ET | 9371 | 31.68 |
| 12:38 ET | 2631 | 31.625 |
| 12:39 ET | 3362 | 31.68 |
| 12:41 ET | 1700 | 31.7 |
| 12:43 ET | 3700 | 31.67 |
| 12:45 ET | 2200 | 31.68 |
| 12:48 ET | 8236 | 31.71 |
| 12:50 ET | 2525 | 31.69 |
| 12:52 ET | 2250 | 31.69 |
| 12:54 ET | 4125 | 31.75 |
| 12:56 ET | 5193 | 31.95 |
| 12:57 ET | 2900 | 31.9 |
| 12:59 ET | 4249 | 32.08 |
| 01:01 ET | 5821 | 32.07 |
| 01:03 ET | 4825 | 32.16 |
| 01:06 ET | 3100 | 32.17 |
| 01:08 ET | 3500 | 32.16 |
| 01:10 ET | 1500 | 32.21 |
| 01:12 ET | 6431 | 31.8 |
| 01:14 ET | 3200 | 31.905 |
| 01:15 ET | 2850 | 31.88 |
| 01:17 ET | 4400 | 31.96 |
| 01:19 ET | 5700 | 32.0025 |
| 01:21 ET | 4659 | 31.9275 |
| 01:24 ET | 6240 | 31.67 |
| 01:26 ET | 3100 | 31.62 |
| 01:28 ET | 4250 | 31.55 |
| 01:30 ET | 9272 | 31.78 |
| 01:32 ET | 1593 | 31.78 |
| 01:33 ET | 4800 | 31.58 |
| 01:35 ET | 689 | 31.61 |
| 01:37 ET | 6909 | 31.6 |
| 01:39 ET | 1600 | 31.65 |
| 01:42 ET | 5783 | 31.5 |
| 01:44 ET | 2500 | 31.48 |
| 01:46 ET | 7859 | 31.575 |
| 01:48 ET | 2200 | 31.53 |
| 01:50 ET | 5296 | 31.7 |
| 01:51 ET | 3412 | 31.62 |
| 01:53 ET | 5156 | 31.49 |
| 01:55 ET | 2341 | 31.545 |
| 01:57 ET | 4098 | 31.4 |
| 02:00 ET | 2350 | 31.27 |
| 02:02 ET | 3058 | 31.335 |
| 02:04 ET | 4507 | 31.12 |
| 02:06 ET | 6833 | 31.185 |
| 02:08 ET | 4047 | 31.375 |
| 02:09 ET | 1750 | 31.43 |
| 02:11 ET | 2499 | 31.45 |
| 02:13 ET | 2450 | 31.42 |
| 02:15 ET | 3482 | 31.45 |
| 02:18 ET | 3862 | 31.54 |
| 02:20 ET | 6478 | 31.25 |
| 02:22 ET | 180 | 31.265 |
| 02:24 ET | 6348 | 31.42 |
| 02:26 ET | 3198 | 31.405 |
| 02:27 ET | 2526 | 31.4 |
| 02:29 ET | 5992 | 31.5 |
| 02:31 ET | 1050 | 31.44 |
| 02:33 ET | 2150 | 31.5 |
| 02:36 ET | 3495 | 31.45 |
| 02:38 ET | 4838 | 31.32 |
| 02:40 ET | 3006 | 31.055 |
| 02:42 ET | 5096 | 31.1425 |
| 02:44 ET | 6010 | 31.3 |
| 02:45 ET | 3660 | 31.29 |
| 02:47 ET | 2279 | 31.31 |
| 02:49 ET | 4451 | 31.17 |
| 02:51 ET | 2241 | 31.04 |
| 02:54 ET | 5133 | 31.28 |
| 02:56 ET | 1450 | 31.36 |
| 02:58 ET | 1900 | 31.39 |
| 03:00 ET | 3143 | 31.46 |
| 03:02 ET | 6150 | 31.395 |
| 03:03 ET | 600 | 31.315 |
| 03:05 ET | 4723 | 31.43 |
| 03:07 ET | 3140 | 31.46 |
| 03:09 ET | 4046 | 31.52 |
| 03:12 ET | 2700 | 31.5 |
| 03:14 ET | 4778 | 31.51 |
| 03:16 ET | 2106 | 31.55 |
| 03:18 ET | 3350 | 31.45 |
| 03:20 ET | 1480 | 31.405 |
| 03:21 ET | 4225 | 31.39 |
| 03:23 ET | 4398 | 31.5 |
| 03:25 ET | 3177 | 31.49 |
| 03:27 ET | 5095 | 31.66 |
| 03:30 ET | 3112 | 31.63 |
| 03:32 ET | 3826 | 31.81 |
| 03:34 ET | 5606 | 31.6 |
| 03:36 ET | 4302 | 31.455 |
| 03:38 ET | 3921 | 31.58 |
| 03:39 ET | 5027 | 31.77 |
| 03:41 ET | 7257 | 31.71 |
| 03:43 ET | 4526 | 31.68 |
| 03:45 ET | 7271 | 31.57 |
| 03:48 ET | 8923 | 31.42 |
| 03:50 ET | 7545 | 31.395 |
| 03:52 ET | 19625 | 31.57 |
| 03:54 ET | 8946 | 31.61 |
| 03:56 ET | 13223 | 31.46 |
| 03:57 ET | 9699 | 31.48 |
| 03:59 ET | 13236 | 31.43 |
Jun 18, 2024
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec, from 8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 6, 2024
May 28, 2024
DJ CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co., from 6:35AM ET on Tuesday May 28, 2024 by Dow Jones
6:35AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CG Oncology Inc | 2.1B | -27.9x | --- |
Rocket Pharmaceuticals Inc | 2.0B | -7.8x | --- |
Janux Therapeutics Inc | 2.1B | -33.5x | --- |
Apogee Therapeutics Inc | 2.2B | -18.6x | --- |
Vera Therapeutics Inc | 2.0B | -17.6x | --- |
Iovance Biotherapeutics Inc | 2.2B | -4.4x | --- |
Company Information
CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The Company’s product candidate, cretostimogene is initially in clinical development for the treatment of patients with non-muscle invasive bladder cancer (NMIBC). Its lead candidate, BOND-003 is a targeted oncolytic intravesically delivered immunotherapy agent that is in Phase II for the treatment of Bacillus Calmette Guerin (BCG) unresponsive and intermediate risk NMIBC disease. Its other product candidate CORE-001 is a Phase II single-arm, open-label clinical trial of cretostimogene administered with BCG-unresponsive NMIBC. Its portfolio also includes PIVOT-006, a Phase III trial to assess the safety and efficacy of adjuvant cretostimogene when administered as monotherapy to patients with intermediate-risk NMIBC following transurethral resection of the bladder tumor (TURBT).
Contact Information
- Headquarters
- 400 Spectrum Center Drive, Suite 2040IRVINE, CA, United States 92618
- Phone
- 949-288-6298
- Fax
- 302-531-3150
Executives
- Chairman of the Board, Chief Executive Officer
- Arthur Kuan
- President, Chief Operating Officer
- Ambaw Bellete
- Chief Financial Officer
- Stephen Dipalma
- Chief Medical Officer
- Vijay Kasturi
- Lead Independent Director
- Leonard Post
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $539.0K |
Shares Outstanding | 66.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.13 |
Book Value | $2.91 |
P/E Ratio | -27.9x |
Price/Sales (TTM) | 3,885.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,652.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
